614 related articles for article (PubMed ID: 15650341)
1. The hypoglycemic effects of soy isoflavones on postmenopausal women.
Cheng SY; Shaw NS; Tsai KS; Chen CY
J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
Ho SC; Chen YM; Ho SS; Woo JL
Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
[TBL] [Abstract][Full Text] [Related]
3. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy.
Petri Nahas E; Nahás Neto J; De Luca L; Traiman P; Pontes A; Dalben I
Maturitas; 2004 Aug; 48(4):372-80. PubMed ID: 15283929
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.
Kaari C; Haidar MA; Júnior JM; Nunes MG; Quadros LG; Kemp C; Stavale JN; Baracat EC
Maturitas; 2006 Jan; 53(1):49-58. PubMed ID: 16257151
[TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
6. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
[TBL] [Abstract][Full Text] [Related]
7. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women.
Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance.
Llaneza P; Gonzalez C; Fernandez-Iñarrea J; Alonso A; Diaz-Fernandez MJ; Arnott I; Ferrer-Barriendos J
Menopause; 2010 Mar; 17(2):372-8. PubMed ID: 20216276
[TBL] [Abstract][Full Text] [Related]
9. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
10. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
11. Effect of soy isoflavone protein and soy lecithin on endothelial function in healthy postmenopausal women.
Evans M; Njike VY; Hoxley M; Pearson M; Katz DL
Menopause; 2007; 14(1):141-9. PubMed ID: 17006376
[TBL] [Abstract][Full Text] [Related]
12. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women.
Fournier LR; Ryan Borchers TA; Robison LM; Wiediger M; Park JS; Chew BP; McGuire MK; Sclar DA; Skaer TL; Beerman KA
J Nutr Health Aging; 2007; 11(2):155-64. PubMed ID: 17435957
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women.
Garrido A; De la Maza MP; Hirsch S; Valladares L
Maturitas; 2006 Jun; 54(3):270-6. PubMed ID: 16414215
[TBL] [Abstract][Full Text] [Related]
14. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
[TBL] [Abstract][Full Text] [Related]
15. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial.
Ho SC; Chan AS; Ho YP; So EK; Sham A; Zee B; Woo JL
Menopause; 2007; 14(3 Pt 1):489-99. PubMed ID: 17308499
[TBL] [Abstract][Full Text] [Related]
16. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women.
Harkness LS; Fiedler K; Sehgal AR; Oravec D; Lerner E
J Womens Health (Larchmt); 2004 Nov; 13(9):1000-7. PubMed ID: 15665657
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
[TBL] [Abstract][Full Text] [Related]
18. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
[TBL] [Abstract][Full Text] [Related]
19. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
Lobo RA; Pickar JH; Wild RA; Walsh B; Hirvonen E
Obstet Gynecol; 1994 Dec; 84(6):987-95. PubMed ID: 7970483
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
